Metraipolis › archive › dc_3acca2fbe03f

Ability of SLE-DAS and SLEDAI-2K to predict damage accrual in SLE: a real-world 7-year cohort study from Sweden — Europe PMC PMID:42811191

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42811191
DOI
10.1093/rheumatology/keag545
License (as archived)
solo-consultazione
Archived
2026-10-31T07:51:15.422Z
SHA-256 of the archived text
681295bd5593520ff8bb1245fb5e1777a245862b22d6c84dbe7cc0d959a0b866
Stable URL of this page
https://metraipolis.com/documento/dc_3acca2fbe03f

How to cite

Ability of SLE-DAS and SLEDAI-2K to predict damage accrual in SLE: a real-world 7-year cohort study from Sweden — Europe PMC PMID:42811191 — Europe PMC (en), https://europepmc.org/article/MED/42811191 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3acca2fbe03f (Metraipolis archive dc_3acca2fbe03f, sha256 681295bd5593520ff8bb1245fb5e1777a245862b22d6c84dbe7cc0d959a0b866)
BibTeX
@misc{dc3acca2fbe03f,
  title = {Ability of SLE-DAS and SLEDAI-2K to predict damage accrual in SLE: a real-world 7-year cohort study from Sweden — Europe PMC PMID:42811191},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42811191},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3acca2fbe03f; sha256 681295bd5593520ff8bb1245fb5e1777a245862b22d6c84dbe7cc0d959a0b866},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42811191. Agents can read the archived copy with the MCP tool read_document.